To Sign or Not to Sign FDA Form 1572?
Exploring that pivotal question for clinical investigators, sponsors, and global CROs.
Scientific Advances Require Innovative Clinical Research Models
FDA is testing various strategies to streamline research and regulatory oversight by looking to novel clinical trial designs to advance new treatments.
Patient Experiences with Clinical Trial Medicines and Instructions
Providing easy to understand and culturally appropriate investigational medication education and support can make all the difference in improving the patient experience.
A Glimmer Is All That’s Needed for Alzheimer’s
Although Biogen's Alzheimer's drug BAN2401 addresses buildup of amyloid plaques, investors and scientists look to reevaluate the plaque theory and search for a glimmer of hope in breakthrough treatments.
CROs To See 12% Yearly Growth to 2021
The Business Research Company publishes a report that the global market for clinical trial services to biopharmaceutical and medical device companies is forecast to grow at 12% year-on-year to 2021.
Does The EU Really Care About Health Policy?
A continued struggle for healthcare and healthcare innovation to be taken seriously by the EU.
Can Sponsors Answer 6 Questions Regulators Ask During Audits?
Switching from paper records to an electronic drug accountability IRT system can benefit sites during FDA trial site audits.
BlockChain in Clinical Trials—the Ultimate Data Notary
Assessing the benefits of using blockchain technology as a notary service in the network sharing of clinical data.
Clinical Trials Don't Have to Cost Too Much or Take Too Long
Analyzing data to reveal site performance patterns for better trial planning and execution.
Applied Clinical Trials, July/August 2018 Issue (PDF)
Click the title above to open the Applied Clinical Trials July/August 2018 issue in an interactive PDF format.
